Analyst Ratings for Eli Lilly (LLY) [Sells]
LLY Rating Summary
LLY Price Target Summary
- Highest: $722.00 (Morgan Stanley)
- Lowest: $270.00 (Atlantic Equities)
- Average: $580.95
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$580.95 (-1.8%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
Avg. $ Target:
$580.95 (-1.8%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/15/2023 | Societe Generale | Florent Cespedes | Downgrade | Sell (Hold) |
278.00 (N/A) |
347.56 (591.60) |
70.22% | Details |
| 1/17/2013 | CLSA | N/A | New Coverage | Sell (5) (N/A) |
47.00 (N/A) |
52.93 (591.60) |
1017.7% | Details |
